Missouri Delta Mammography introduces ProFound AI™, the first FDA-Cleared 3D mammography software using artificial intelligence
Breast cancer screening has improved significantly in recent years with the advent of 3D mammography, or digital breast tomosynthesis (DBT). While traditional 2D mammography typically yields four images per patient, 3D mammography produces hundreds of images per patient, providing doctors with more information and better images than ever before. DBT helps doctors find cancers earlier, when they may be more easily treated, with fewer false positives, which can be stressful for patients.
Our facility recently adopted new technology that further maximizes the benefits DBT offers to women. ProFound AI™ for DBT is the first FDA-cleared 3D tomosynthesis software using artificial intelligence (AI). The technology is FDA-cleared and clinically proven to enhance breast cancer detection, while significantly reducing the rate of false positives and unnecessary recalls for women.
What is a 3D mammography breast exam?
3D mammography is a revolutionary new screening and diagnostic tool designed for early breast cancer detection that can be done in conjunction with a traditional 2D digital mammogram.
During the 3D part of the exam, the X-ray arm sweeps in a slight arc over your breast, taking multiple breast images. Then, a computer produces a 3D image of your breast tissue in one millimeter slices, providing greater visibility for the radiologist to see breast detail in a way never before possible. They can scroll through images of your entire breast like pages of a book.
The additional 3D images make it possible for a radiologist to gain a better understanding of your breast tissue during screening and the confidence to reduce the need for follow-up imaging.
How does ProFound AI work?
ProFound AI for DBT acts as another pair of eyes for radiologists reviewing 3D mammography images. Built with the latest in artificial intelligence, it rapidly and accurately analyzes each 3D mammogram image, detecting cancers with unrivaled accuracy. It provides crucial information to your doctor and alerts them if suspicious areas may warrant a closer look.
ProFound AI for DBT is FDA-cleared and clinically proven in a large reader study to improve cancer detection by 8% and reduce the rate of false positives and unnecessary recalls for women by 7%.
